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Improved diagnostics are needed for children with musculo-
skeletal infections (MSKIs). We assessed the performance of 
target-enriched multiplex polymerase chain reaction (TEM-
PCR) in children with MSKI. TEM-PCR was concordant with 
culture in pathogen identification and antibiotic susceptibility 
testing, while increasing the overall yield of pathogen detec-
tion. This technology has the potential to inform judicious anti-
microbial use early in the disease course.
Keywords.  diagnostics; musculoskeletal infections; 
osteomyelitis; pediatrics; septic arthritis.
 
Musculoskeletal infections (MSKIs; osteomyelitis, septic arth-
ritis, and pyomyositis) require prompt diagnosis and treatment 
due to the risk of local tissue damage and metastatic bacterial 
spread. Currently, pathogen identification requires culture from 
a sterile site (eg, blood, bone, or joint fluid); however, nearly 
half of all MSKIs in children remain culture-negative [1–3]. The 
absence of pathogen identification has important implications 
for the treatment of children with MSKI as the prevalence of 
community-associated methicillin-resistant Staphylococcus 
aureus (CA-MRSA) often justifies broad empiric antibiotic 
regimens. Additionally, resistance to commonly used anti-
staphylococcal antibiotics continues to increase across multi-
ple antibiotic classes and among both methicillin-resistant and 
methicillin-susceptible S. aureus (MSSA) strains [4–6]. Taken 
together, it has become increasingly difficult to select empiric 
antimicrobial regimens with sufficient breadth and safety.
Molecular diagnostic methods, such as polymerase chain 
reaction (PCR), provide the ability to rapidly and reliably detect 
pathogens and are less affected by the barriers inherent to path-
ogen identification by culture (eg, failure to detect fastidious 
growth of organisms, false negativity due to preculture antibiotic 
exposure). Target-enriched multiplex PCR (TEM-PCR), first 
described in 2006 [7], is a highly flexible diagnostic platform, 
capable of identifying a large spectrum of pathogens and anti-
biotic resistance targets in a single sample with high sensitivity 
and specificity. Thus, in this proof-of-concept study, we sought 
to evaluate the utility of TEM-PCR in children with MSKI.
METHODS
Patient Enrollment and Specimen Collection
For 1  year (January 2016 to January 2017), we prospectively 
enrolled children age 6  months to 18  years who were admit-
ted to the Monroe Carell Jr. Children’s Hospital at Vanderbilt 
(MCJCHV) with acute MSKI undergoing a surgical drainage/
biopsy procedure. Potential study subjects were identified by daily 
communication with the pediatric orthopedic surgery service.
Source specimens were collected per standard of care in 
accordance with the preference of the treating physician (bone 
biopsy for osteomyelitis, fluid aspiration for septic arthritis, sub-
periosteal abscess [when applicable], and pyomyositis) in the 
operating room and sent to the Vanderbilt University Medical 
Center Clinical Laboratory for bacterial culture. Additionally, 
2 mL of synovial fluid (in cases of septic arthritis) or a swab of 
the infected area of bone (in cases of osteomyelitis) was placed 
into an ESwab transport tube (Copan, Brescia, Italy) for TEM-
PCR and stored at –80°C until processing. Following enrollment, 
subjects were monitored using the Vanderbilt Electronic Medical 
Record to determine whether a pathogen was isolated by culture.
Informed consent was obtained from the parents, and 
informed assent was obtained from the participant when pos-
sible, before inclusion in the study. The study was approved by 
the Vanderbilt University Medical Center Institutional Review 
Board (IRB).
Specimen Processing for TEM-PCR
Blinded clinical samples were submitted to Diatherix-Eurofins 
for TEM-PCR detection of Kingella kingae, Haemophilus influ-
enzae, Streptococcus pyogenes, Streptococcus pneumoniae, S. aur-
eus, methicillin (mecA) and clindamycin/erythromycin (ermA, 
ermC) resistance genes, and the Panton-Valentine leukocidin 
(PVL) locus. Briefly, nucleic acid was extracted from 275 µL of 
clinical sample, and 20-µL PCR reactions were prepared using 
Open Forum Infectious Diseases®
© The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases 
Society of America. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/
by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any 
medium, provided the original work is not altered or transformed in any way, and that the work 
is properly cited. For commercial re-use, please contact journals.permissions@oup.com
DOI: 10.1093/ofid/ofy119
Received 26 March 2018; editorial decision 9 May 2018; accepted 18 May 2018; published 
online May 22, 2018.
Correspondence: J. Wood, MD, MSCI, Indiana University School of Medicine, 410 W. 10th 
Street, St 2000A, Indianapolis, IN 46202 (woodjb@iu.edu).
2 • OFID • BRIEF REPORT
2X Platinum Multiplex Master Mix (ThermoFisher Scientific, 
Waltham, MA), 2.4 µL of TEM-PCR primer mix, and 4 µL of tem-
plate DNA. Amplification was performed in 96-well plates on 
the GeneAmp PCR System 9700 thermocycler (ThermoFisher 
Scientific, Waltham, MA). In a single reaction, each target was 
amplified with nested primers and subsequently amplified with 
a pair of universal primers containing proprietary sequences to 
amplify all targets in the single reaction. The reverse universal 
primer was biotinylated for downstream detection. Biotinylated 
amplicons were detected by hybridization to a detection 
probe covalently coupled to a glass microarray substrate, and 
streptavidin-phycoerythrin conjugate was added. Fluorescent 
signal emission was measured on a SensoSpot imaging reader 
(Sensovation AG, Radolfzell, Germany).
Data Analysis
Demographic data were collected from the electronic medical 
record system at MCJCHV. Sensitivity and negative predictive 
values were calculated to compare TEM-PCR to culture.
RESULTS
Patient Characteristics
During the study period, 25 source specimens were collected 
for culture and TEM-PCR on 24 patients (1 subject was admit-
ted twice, 2  months apart). Fourteen (58%) participants were 
male, with a median age (interquartile range) of 8 (3–12) years. 
Seventy-one percent of the patients were non-Hispanic white, 
25% were non-Hispanic black, and 4% were multiracial. Fifty-
two percent of the samples came from patients with septic arth-
ritis (8 hips, 4 knees, 1 shoulder); 28% had osteomyelitis (3 
femoral, 2 tibial, 1 fibular, 1 foot); 16% had combined osteomy-
elitis and septic arthritis (2 upper extremity, 2 lower extremity), 
and 4% had an isolated pyomyositis (gluteal). Sixty percent of 
patients were treated with at least 1 dose of antibiotics before 
source sample collection.
Pathogen Identification and Antibiotic Susceptibility Testing by Culture
An organism was isolated by bacterial culture in 17 of 25 speci-
mens (68%) (Table 1); all were S. aureus. Five of the 17 S. aureus 
isolates were methicillin-resistant (MRSA), 2 were clindamy-
cin-resistant (both MSSA), and 8 were erythromycin-resistant.
Pathogen Identification and Antibiotic Resistance Detection by TEM-PCR
Using TEM-PCR, an organism was detected in 20 of 25 speci-
mens (80%) (Table 1). S. aureus was detected in 18 specimens, 
and K. kingae was detected in 2 specimens. Of the 18 S. aureus 
positive specimens, 5 were methicillin-resistant (MRSA), 2 were 
clindamycin-resistant, and 2 were erythromycin-resistant. Nine 
of 18 (50%) S. aureus isolates were positive for the PVL gene.
Performance of TEM-PCR Compared With Culture
TEM-PCR was concordant with 17 of the 17 (100%) pathogens 
isolated by culture. Three pathogens were detected by TEM-
PCR that were not detected by culture, all of which received 
antibiotic therapy before source specimen collection. Of these 
3, 2 were K. kingae and 1 was S. aureus, which was previously 
isolated in the same patient by culture and TEM-PCR in their 
previous hospital admission. Five specimens were negative by 
both culture and TEM-PCR. There were no specimens with a 
positive culture and negative TEM-PCR.
Overall, TEM-PCR exhibited 100% concordance with pos-
itive culture samples and identified 3 pathogens that, while 
negative by culture, were considered by study investigators to 
be highly likely to be the causative pathogen based on clinical 
characteristics. Compared with culture, TEM-PCR had a sen-
sitivity and negative predictive value of 100%. Specificity and 
positive predictive values were not calculated, as the specimens 
positive by TEM-PCR and negative by culture were not consid-
ered “false positives.”
Compared with culture, TEM-PCR identified 5 of 5 (100%) 
methicillin-resistant S.  aureus, 2 of 2 (100%) clindamycin-re-
sistant S.  aureus, and 2 of 8 (25%) erythromycin-resistant 
S. aureus (Table 1).
DISCUSSION
This study provides insight into the utility of TEM-PCR for 
children with MSKI. The results show that TEM-PCR was 
highly concordant with culture-based testing (reference stand-
ard) in pathogen identification for children with MSKI and 
outperformed traditional culture, increasing overall pathogen 
detection from 68% to 80%. Additionally, TEM-PCR reliably 
detected methicillin and clindamycin resistance in S.  aureus 
isolates. These results suggest that TEM-PCR has the poten-
tial to inform antibiotic selection early in the disease course, 
decreasing the use of broad-spectrum empiric antibiotic regi-
mens and promoting antimicrobial stewardship.
The identification of a causative organism in MSKI is crit-
ical and allows for optimal targeted antimicrobial therapy. 
Traditionally, clinicians have relied on bacterial culture for path-
ogen isolation and antibiotic susceptibility testing, although 
blood and operative cultures frequently remain negative [1–3]. 
Several reasons for this exist, including antibiotic administra-
tion before tissue sampling and the fastidious nature of causa-
tive pathogens.
K.  kingae is a fastidious gram-negative organism that is 
increasingly recognized as an important pathogen causing 
MSKI, especially in children <4  years of age [8]. Despite the 
importance of this pathogen, the culture yield remains very 
low, even under optimal conditions [9]. PCR has been shown 
to greatly increase the rate of pathogen identification in cases of 
MSKI due to K. kingae [10]. Our study supports this finding, as 
K. kingae was identified by TEM-PCR in 2 cases where cultures 
remained negative.
In addition to increasing pathogen identification, TEM-PCR 
can rapidly provide information on antibiotic susceptibility 
testing (AST), allowing for timely optimization of antibiotics. 
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Clinical specimens submitted for TEM-PCR testing are batched 
by panel type and processed daily, and test results are reported 
to physicians within 7 hours of specimen receipt in the labora-
tory. Culture-based methods often take 24–48 hours to identify 
a pathogen and an additional 24–48 hours until AST is com-
plete. This 48–96-hour delay leads to prolonged broad-spec-
trum empiric antimicrobial exposure until AST is secured. In 
our study, TEM-PCR was 100% concordant with culture-based 
methods for methicillin and clindamycin resistance testing. The 
lower erythromycin resistance detection by TEM-PCR is most 
likely due to the limited targets selected for this assay (ermA 
and ermC), though this may also be a result of inadequate 
sensitivity of this component of the multiplex assay. The addi-
tions of ermB, msrA, msrB, and mphC gene targets would likely 
increase erythromycin resistance detection; however, given that 
erythromycin is not used in the treatment of MSKI in children, 
inclusion of these targets has limited clinical utility. Overall, 
TEM-PCR allows for rapid AST results, decreasing time to opti-
mal therapy and increasing antimicrobial stewardship.
There are several limitations to this proof-of-concept study. 
The limited sample size resulted in the identification of only 
2 pathogen species—S. aureus and K. kingae. Although TEM-
PCR has been shown to reliably detect numerous bacterial and 
viral species in other infectious diseases [11–13], the sensitiv-
ity in pediatric MSKI remains unknown. Additionally, despite 
the strong concordance with culture-based methods, the small 
sample size limits the power of the study. Despite these limita-
tions, the high sensitivity and negative predictive values seen in 
this small pilot study suggest that TEM-PCR, as a rapid diag-
nostic tool, can play an important role in the initial evaluation 
of children with MSKI.
Given the challenges of pathogen detection by conventional 
culture in children with MSKI and the increasing number of 
antibiotic-resistant organisms, there is a major need for opti-
mizing diagnostic strategies. Recent studies have investigated 
the utility of K.  kingae–specific PCR in children with MSKI, 
as well as broad-range PCR for prosthetic joint infections 
[8, 14]. Few studies, however, have described the utility of a flex-
ible, well-developed platform in detecting the common patho-
gens of pediatric MSKI. TEM-PCR provides rapid results with 
high sensitivity utilizing a multiplex panel that targets likely 
pathogens and known antibiotic resistance mechanisms, and 
further investigation of this technology is warranted.
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